TWO SIGMA INVESTMENTS, LP

Position in IFRX — InflaRx N.V.

CIK 1179392 NEW YORK, NY

Position in IFRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$169,033

-$241,345 QoQ

Shares Held

189,075

-53.5% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. IFRX ranks #272 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,992,577	$659,283,951
2	REGN	Regeneron Pharmaceuticals, Inc.	812,236	$627,566,023
3	MRNA	Moderna, Inc.	9,086,404	$461,589,323
4	IONS	Ionis Pharmaceuticals Inc	5,857,629	$439,849,361
5	BBIO	BridgeBio Pharma, Inc.	3,120,631	$231,738,058
6	VRTX	Vertex Pharmaceuticals Inc / Ma	378,146	$168,857,314
7	RVMD	Revolution Medicines, Inc.	1,558,807	$151,593,980
8	VKTX	Viking Therapeutics, Inc.	4,432,142	$144,221,900

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$169,033	189,075	-53.5%	Shares	Sole	2026-05-15
2025-12-31	$410,378	406,315	+1960.8%	Shares	Sole	2026-02-17
2024-12-31	$48,698	19,716	-17.9%	Shares	Sole	2025-02-14
2024-09-30	$36,739	24,013	-53.4%	Shares	Sole	2024-11-14
2024-06-30	$89,681	51,541	-49.6%	Shares	Sole	2024-08-14
2024-03-31	$157,411	102,215	-26.1%	Shares	Sole	2024-05-15
2023-12-31	$225,551	138,375	+1013.7%	Shares	Sole	2024-02-14
2023-09-30	$37,026	12,425	-74.8%	Shares	Sole	2023-11-14
2022-03-31	$90,083	49,226	-18.2%	Shares	Sole	2022-05-16
2021-12-31	$286,404	60,169	+443.5%	Shares	Sole	2022-02-14
2021-09-30	$28,671	11,070	-83.4%	Shares	Sole	2021-11-15
2020-06-30	$305,859	66,636	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.